e-learning
resources
London 2016
Monday, 05.09.2016
Late-breaking topics in airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Exploiting the ability of 1H-NMR to differentiate patients with severe alpha-1-antitrypsin deficiency from controls based on metabolome profiling of exhaled breath condensate
Jan Stolk (Leiden, Netherlands), M. Fumagalli, Jan Stolk, C. Ciaramelli, R. Bussei, V. Mazzoni, S. Viglio, Paolo Iadarola, C. Airoldi
Source:
International Congress 2016 – Late-breaking topics in airways disease
Session:
Late-breaking topics in airways disease
Session type:
Oral Presentation
Number:
1971
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jan Stolk (Leiden, Netherlands), M. Fumagalli, Jan Stolk, C. Ciaramelli, R. Bussei, V. Mazzoni, S. Viglio, Paolo Iadarola, C. Airoldi. LATE-BREAKING ABSTRACT: Exploiting the ability of 1H-NMR to differentiate patients with severe alpha-1-antitrypsin deficiency from controls based on metabolome profiling of exhaled breath condensate. Eur Respir J 2016; 48: Suppl. 60, 1971
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Influence of inflammatory phenotype in severe refractory asthma on metabolomic profile of oxidative stress in exhaled breath condensate (EBC)
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Unbiased clustering of severe asthma patients based on exhaled breath profiles
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016
Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011
Decreased levels of bis-S-bimane in exhaled breath condensate of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
Identification of MDA associated clusters in exhaled breath samples of patient measurements from GC-IMS spectra
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019
Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes.
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Exhaled breath condensate sample collection: standards and open issues
Source: Eur Respir Monogr 2010; 49: 152-161
Year: 2010
Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006
Distinct arginine and tryptophan metabolism in mild and severe asthma as compared to controls based upon analyses of exhaled breath condensate
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study
Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017
Year: 2018
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients
Source: International Congress 2017 – Management of COPD
Year: 2017
Measuring exhaled NO and breath condensate: where do we stand?
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006
Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept